Masimo accuses Tyco of anti-competitive acts
This article was originally published in Clinica
Executive Summary
Pulse oximetry company Masimo has accused Tyco Healthcare of employing anti-competitive business practices in order to protect its monopoly position in the US market for pulse oximetry sensors and patient cables. The company is seeking recovering of damages and injunctive relief.